New UK clinical trial laws aim for faster research approvals
FierceBiotech - 14-Apr-2025New funding and better access are part of efforts to make Britain leader in medical innovation
Join the club for FREE to access the whole archive and other member benefits.
Staff writer for Fierce Biotech
Darren Incorvaia is a science journalist currently writing for Fierce Biotech, where he came on board in 2024. His work has appeared in prominent outlets including The New York Times, Science, and Science News. In 2023, he was selected as an early-career fellow at The Open Notebook. Darren holds a Ph.D. in Ecology, Evolution, and Behavior from Michigan State University and has a deep fondness for animals—particularly the spineless kind.
Visit website: https://www.fiercebiotech.com/person/darren-incorvaia
See also
Web resource providing the latest biotech news, articles, and resources related to biotech company news
Details last updated 07-Apr-2025
New funding and better access are part of efforts to make Britain leader in medical innovation
Backed by Nobel science, the Alphabet spinout speeds up AI drug development